Photodynamic Therapy in Occult-Only Lesions (POOL)

Sponsor
Novartis
Study ID
NCT00135837
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

Age related macular degeneration is the leading cause of blindness for people over 50 in the western world. Blood vessels which start to grow form a lesion in the back of the eye. Verteporfin may stabilize the disease, by closing the blood vessels. This study will assess the efficacy and safety of verteporfin in patients with occult only lesions.

Key Dates

Start date
Jun 30, 2003
Status verified
Jun 2006

Study Design

Enrollment
202 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

visual acuity measurements, baseline, 12 months

Related Studies